Tiotropium+Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)

NCT01431274 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2624

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: tiotropium + olodaterol
DRUG: tiotropium
DRUG: olodaterol
DRUG: tiotropium
DRUG: tiotropium + olodaterol
DEVICE: Respimat

Sponsor

Boehringer Ingelheim